Bullish
Acadia Pharma Stock Jumps After European Panel Reverses Course On Rett Syndrome Therapy
Acadia Pharmaceuticals (ACAD) stock jumped following a positive recommendation from the European Medicines Agency's CHMP for its drug DAYBU (trofineti...